Search
Amicus Therapeutics Inc
FOLDAdd to Watchlist
14.490USD
0.0000.00%
Close 06/18, 16:00（ET）Quotes delayed by 15 min
4.55BMarket Cap
LossP/E TTM
Amicus Therapeutics Inc's Company Valuation
Currency: USD Updated: 2026-04-24The current valuation score of Amicus Therapeutics Inc is 7.84, ranking 76 out of 389 in the Biotechnology & Medical Research industry. Its current P/E ratio is -164.81, which is -91.91% below the recent high of -13.33 and -95.68% above the recent low of -322.49.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.
